HekaBio
HekaBio is a healthcare development and investment platform focused on advancing innovations in oncology, radiation, and cardiovascular therapies. The company specializes in offering a wide range of development expertise, including pharmaceuticals, medical devices, in-vitro diagnostics, digital health, and cell and gene therapies. HekaBio aims to support researchers in advancing breakthrough programs while facilitating accelerated access to global healthcare innovations for patients. By investing in and commercializing these healthcare technologies, HekaBio plays a crucial role in improving treatment options for oncology and fibrotic diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.